Logo image of LGMK

LOGICMARK INC (LGMK) Stock Fundamental Analysis

NASDAQ:LGMK - Nasdaq - US67091J6029 - Common Stock - Currency: USD

0.0129  0 (-5.15%)

After market: 0.0126 0 (-2.33%)

Fundamental Rating

2

Taking everything into account, LGMK scores 2 out of 10 in our fundamental rating. LGMK was compared to 189 industry peers in the Health Care Equipment & Supplies industry. The financial health of LGMK is average, but there are quite some concerns on its profitability. LGMK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year LGMK has reported negative net income.
In the past year LGMK has reported a negative cash flow from operations.
In the past 5 years LGMK always reported negative net income.
In the past 5 years LGMK always reported negative operating cash flow.
LGMK Yearly Net Income VS EBIT VS OCF VS FCFLGMK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

The Return On Assets of LGMK (-65.42%) is worse than 72.49% of its industry peers.
Looking at the Return On Equity, with a value of -76.31%, LGMK is in line with its industry, outperforming 41.27% of the companies in the same industry.
Industry RankSector Rank
ROA -65.42%
ROE -76.31%
ROIC N/A
ROA(3y)-62.15%
ROA(5y)-49.38%
ROE(3y)-71.32%
ROE(5y)-59.48%
ROIC(3y)N/A
ROIC(5y)N/A
LGMK Yearly ROA, ROE, ROICLGMK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

LGMK has a Gross Margin of 66.81%. This is in the better half of the industry: LGMK outperforms 71.43% of its industry peers.
LGMK's Gross Margin has declined in the last couple of years.
LGMK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5%
GM growth 5Y-2.16%
LGMK Yearly Profit, Operating, Gross MarginsLGMK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

6

2. Health

2.1 Basic Checks

LGMK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LGMK has more shares outstanding
The number of shares outstanding for LGMK has been increased compared to 5 years ago.
LGMK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LGMK Yearly Shares OutstandingLGMK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
LGMK Yearly Total Debt VS Total AssetsLGMK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

LGMK has an Altman-Z score of -11.31. This is a bad value and indicates that LGMK is not financially healthy and even has some risk of bankruptcy.
LGMK has a worse Altman-Z score (-11.31) than 80.42% of its industry peers.
There is no outstanding debt for LGMK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -11.31
ROIC/WACCN/A
WACC9.1%
LGMK Yearly LT Debt VS Equity VS FCFLGMK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

LGMK has a Current Ratio of 2.63. This indicates that LGMK is financially healthy and has no problem in meeting its short term obligations.
LGMK has a Current ratio of 2.63. This is comparable to the rest of the industry: LGMK outperforms 50.79% of its industry peers.
LGMK has a Quick Ratio of 2.11. This indicates that LGMK is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.11, LGMK is in line with its industry, outperforming 50.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.63
Quick Ratio 2.11
LGMK Yearly Current Assets VS Current LiabilitesLGMK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

More info and screens

0

3. Growth

3.1 Past

LGMK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -393.42%.
The Revenue has decreased by -0.28% in the past year.
The Revenue for LGMK have been decreasing by -10.39% on average. This is quite bad
EPS 1Y (TTM)-393.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-669.36%
Revenue 1Y (TTM)-0.28%
Revenue growth 3Y-0.4%
Revenue growth 5Y-10.39%
Sales Q2Q%-7.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y99.79%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.72%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LGMK Yearly Revenue VS EstimatesLGMK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
LGMK Yearly EPS VS EstimatesLGMK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2023 2024 2025 -5K -10K -15K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

LGMK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LGMK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LGMK Price Earnings VS Forward Price EarningsLGMK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LGMK Per share dataLGMK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LGMK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LOGICMARK INC

NASDAQ:LGMK (5/20/2025, 8:12:05 PM)

After market: 0.0126 0 (-2.33%)

0.0129

0 (-5.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-13 2025-05-13
Earnings (Next)08-11 2025-08-11
Inst Owners14.43%
Inst Owner Change38441.3%
Ins Owners8.28%
Ins Owner Change0%
Market Cap781.61K
Analysts43.33
Price Target0.26 (1915.5%)
Short Float %22.15%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.13
Dividend Growth(5Y)N/A
DP-3.22%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-475.72%
Min EPS beat(2)-1005.85%
Max EPS beat(2)54.4%
EPS beat(4)3
Avg EPS beat(4)-233.53%
Min EPS beat(4)-1005.85%
Max EPS beat(4)54.4%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)3.78%
Min Revenue beat(2)-1.22%
Max Revenue beat(2)8.78%
Revenue beat(4)1
Avg Revenue beat(4)-1.44%
Min Revenue beat(4)-9.81%
Max Revenue beat(4)8.78%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-93.75%
PT rev (3m)-93.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.08
P/FCF N/A
P/OCF N/A
P/B 0.06
P/tB 0.23
EV/EBITDA N/A
EPS(TTM)-63.56
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.16
BVpS0.2
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -65.42%
ROE -76.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.81%
FCFM N/A
ROA(3y)-62.15%
ROA(5y)-49.38%
ROE(3y)-71.32%
ROE(5y)-59.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5%
GM growth 5Y-2.16%
F-Score4
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.59%
Cap/Sales 0.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.63
Quick Ratio 2.11
Altman-Z -11.31
F-Score4
WACC9.1%
ROIC/WACCN/A
Cap/Depr(3y)13.92%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.06%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-393.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-669.36%
EPS Next Y99.79%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.28%
Revenue growth 3Y-0.4%
Revenue growth 5Y-10.39%
Sales Q2Q%-7.25%
Revenue Next Year0.72%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.41%
OCF growth 3YN/A
OCF growth 5YN/A